MedPath

Prognostic Model for Resected Borderline and Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy

Not Applicable
Completed
Conditions
Neoplasms
Registration Number
KCT0009203
Lead Sponsor
Asan Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
176
Inclusion Criteria

Among patients who was treated in Seoul Asan Medical Center, those with available preoperative CA 19-9 level and PET result

Exclusion Criteria

No Curative resection, No available preoperativel level of CA 19-9, No available preoperative PET

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
5year Overall survival
Secondary Outcome Measures
NameTimeMethod
Recurrence free survival
© Copyright 2025. All Rights Reserved by MedPath